MedPath

University of California, Los Angeles

University of California, Los Angeles logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1919-05-23
Employees
10K
Market Cap
-
Website
http://www.ucla.edu

Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women

Phase 4
Completed
Conditions
HIV Prevention
Interventions
Behavioral: Text Messaging
Behavioral: Adherence Counseling
Drug: Daily Oral PrEP
First Posted Date
2015-10-22
Last Posted Date
2021-07-08
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
136
Registration Number
NCT02584140
Locations
🇺🇸

Los Angeles Biomedical Research Institute at Harbor-UCLA, Los Angeles, California, United States

🇺🇸

T.H.E. at Ruth Temple, Los Angeles, California, United States

🇺🇸

USC 5P21 Rand Schrader Clinic, Los Angeles, California, United States

and more 2 locations

Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo

Not Applicable
Completed
Conditions
Tourette Disorder
Chronic Tic Disorder
Interventions
Drug: Placebo
Drug: D-cycloserine
First Posted Date
2015-10-21
Last Posted Date
2019-04-25
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
20
Registration Number
NCT02582515
Locations
🇺🇸

UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, United States

Combination Treatment for Augmenting Language in Children With ASD

Phase 2
Completed
Conditions
Autism Spectrum Disorder
Interventions
Behavioral: Behavioral Therapy
Drug: Placebo
Drug: Aripiprazole
First Posted Date
2015-10-14
Last Posted Date
2020-04-29
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
58
Registration Number
NCT02574741
Locations
🇺🇸

University of California, Los Angeles, California, United States

Cannabidiol for Pediatric Epilepsy (Compassionate Use)

Conditions
Refractory Childhood Epilepsy
First Posted Date
2015-09-22
Last Posted Date
2017-05-03
Lead Sponsor
University of California, Los Angeles
Registration Number
NCT02556008
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

Improving Cognition in Schizophrenia Using tDCS

Not Applicable
Completed
Conditions
Schizophrenia
Interventions
Device: tDCS
First Posted Date
2015-09-03
Last Posted Date
2018-03-07
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
37
Registration Number
NCT02539797
Locations
🇺🇸

UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, United States

Web-based Preconception Health Education Tool

Not Applicable
Completed
Conditions
Reproductive Health
Interventions
Behavioral: MyFamilyPlan
First Posted Date
2015-08-20
Last Posted Date
2017-04-10
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
292
Registration Number
NCT02529527
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

Thalamic Low Intensity Focused Ultrasound in Brain Injury

Not Applicable
Terminated
Conditions
Brain Injuries
Consciousness Disorders
Interventions
Device: Low Intensity Focused Ultrasound Device
First Posted Date
2015-08-13
Last Posted Date
2022-12-28
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
23
Registration Number
NCT02522429
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

Is MyPlate Approach to Helping Overweight Patients Lose Weight More Patient-centered?

Not Applicable
Completed
Conditions
Obesity
Interventions
Behavioral: MyPlate
Behavioral: Calorie-counting
First Posted Date
2015-08-04
Last Posted Date
2017-11-20
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
261
Registration Number
NCT02514889
Locations
🇺🇸

The Children's Clinic of Long Beach (TCC), Long Beach, California, United States

🇺🇸

UCLA Center for Cancer Prevention & Control Research, Los Angeles, California, United States

Intermittent Theta Burst Stimulation for MDD

Not Applicable
Suspended
Conditions
Major Depressive Disorder
Interventions
Device: Neuronetics XPLOR system
First Posted Date
2015-07-22
Last Posted Date
2024-08-12
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
30
Registration Number
NCT02506127
Locations
🇺🇸

UCLA TMS Clinic and Research Service, Los Angeles, California, United States

Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine

Phase 4
Completed
Conditions
Schizophrenia
Cognitive Deficits
Schizophrenia; Negative Type
Interventions
Drug: N-acetylcysteine
Other: Treatment as Usual
First Posted Date
2015-07-22
Last Posted Date
2023-05-15
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
51
Registration Number
NCT02505477
Locations
🇺🇸

UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath